Urine macrophage migration inhibitory factor in pediatric systemic lupus erythematosus

Clinical Rheumatology

Volumn 26, Issue 12, 2007, Pages 2105-2107

  Otukesh, Hasan ^a   Chalian, Majid ^a   Hoseini, Rozita ^a   Chalian, Hamid ^a   Hooman, Nakysa ^a   Bedayat, Arash ^a   Yazdi, Reza Salman ^b   Sabaghi, Saeed ^b   Mahdavi, Saeed ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Activity index; Lupus nephritis; Macrophage migration inhibitory factor

Indexed keywords

CREATININE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; INFLAMMATORY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PATHOGENESIS; PEDIATRICS; PRIORITY JOURNAL; RELAPSE; REMISSION; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 36249016836     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0632-z     Document Type: Article

References (8)

1. Foster MH, Kelley VR (1999) Lupus nephritis: Update on pathogenesis and disease mechanisms. Semin Nephrol 19:173-181
2. Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J (2002) Macrophage migration inhibitory factor (MIF): Mechanisms of action and role in disease. Microbes Infect 4:449-460
3. Gregersen PK, Bucala R (2003) Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: Incorporating disease outcome into the definition of phenotype. Arthritis Rheum 48:1171-1176
4. Donn RP, Ray DW (2004) Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 182:1-9
5. Morand EF (2005) New therapeutic target in inflammatory disease: macrophage migration inhibitory factor. Intern Med J 35:419-426
6. Hoi AY, Morand EF, Leech M (2003) Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus? Immunol Cell Biol 81:367-373
7. Brown FG, Nikolic-Paterson DJ, Hill PA, Isbel NM, Dowling J, Metz CM et al (2002) Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol 13:S7-S13
8. Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K et al (2000) Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: Elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 5:397-403